2013
DOI: 10.1021/jm400520c
|View full text |Cite
|
Sign up to set email alerts
|

Functionally Selective Dopamine D2/D3Receptor Agonists Comprising an Enyne Moiety

Abstract: Dopaminergics of types 1 and 2 incorporating a conjugated enyne as an atypical catechol-simulating moiety were synthesized in enantiomerically pure form and investigated for their metabolic stability. Radioligand binding studies indicated high affinity to D2-like receptors. The test compounds were evaluated for their ability to differentially activate distinct signaling pathways. Measurement of D(2L)- and D(2S)-mediated [(35)S]GTPγS incorporation in the presence of coexpressed Gα(o) and Gα(i) subunits showed s… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
93
0

Year Published

2014
2014
2022
2022

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 54 publications
(96 citation statements)
references
References 61 publications
3
93
0
Order By: Relevance
“…15,17 By suggesting that the lipophilic appendages may account for the induction of preferential signaling by addressing particular residues of an extended binding site, we could demonstrate that structurally atypical dopaminergics comprising an enyne moiety and a lipophilic appendage including triazolylalkoxybenzene derivatives are able to discriminate between Gα o1 -and Gα i2 -mediated signaling at D 2L and D 2S receptors. 16 Interestingly, the crystal structure of the 5-HT 2B receptor in complex with the biased agonist ergotamine 20,21 revealed ligand-contacting residues in identical positions, as we suggested by docking studies of D 2 and the functionally selective dopaminergic agent (S)-1 ( Figure 1). This finding indicates the potential existence of conserved receptor microdomains that are responsible for ligand bias.…”
mentioning
confidence: 64%
See 2 more Smart Citations
“…15,17 By suggesting that the lipophilic appendages may account for the induction of preferential signaling by addressing particular residues of an extended binding site, we could demonstrate that structurally atypical dopaminergics comprising an enyne moiety and a lipophilic appendage including triazolylalkoxybenzene derivatives are able to discriminate between Gα o1 -and Gα i2 -mediated signaling at D 2L and D 2S receptors. 16 Interestingly, the crystal structure of the 5-HT 2B receptor in complex with the biased agonist ergotamine 20,21 revealed ligand-contacting residues in identical positions, as we suggested by docking studies of D 2 and the functionally selective dopaminergic agent (S)-1 ( Figure 1). This finding indicates the potential existence of conserved receptor microdomains that are responsible for ligand bias.…”
mentioning
confidence: 64%
“…These results indicate an analogous binding pose as suggested for the enyne analogues of type 1 when the more potent isomer has to be assigned as (S)-1 due to a reversal of nomenclature exerted by the C,O exchange in the structure. 16 Substantial stereospecific binding was observed for the aminotetralines (R)-and (S)-4. Whereas (R)-configuration led to K i values of 18, 30, and 1.2 nM, (S)-4 exhibited subnanomolar K i values of 0.47, 0.54, and 0.21 nM for D 2L , D 2S , and D 3 , respectively.…”
Section: ■ Results and Discussionmentioning
confidence: 95%
See 1 more Smart Citation
“…Later, the role of GRK2 and GRK3 for the non-G-protein dependent signaling pathway was pointed out, highlighting also the importance of IC3 and IC2 as interacting site for β-arrestins in D 3 receptor (Kim et al, 2005), supported by mutations studies on IC3 and IC2 (Lan et al, 2009a(Lan et al, , 2009b. D 3 receptor selective (partial) agonists with tetramethylene (butyl) linker and heteroaromatic or enyne moieties as agonist warhead group have been described as biased (partial) receptor agonist at D 2/3 receptors (Dörfler et al, 2008;Hiller et al, 2013;Möller et al, 2014;Tschammer et al, 2011b). Recently enantioselective D 3 ligands based on 5-aminotetrahydropyrazolopyridine with strong biased signaling properties to D 3 receptor were developed (Tschammer et al, 2011a).…”
Section: Dopamine D 3 Receptor Agonist Signalingmentioning
confidence: 94%
“…The D 2 model was developed previously, 45 whereas the 5-HT 2A model was generated by an analogous procedure using MODELLER 9v4 80 . Prior to docking, both receptors were submitted to energy minimization using the AMBER package 81 …”
Section: Homology Modeling/dockingmentioning
confidence: 99%